NHS: Drugs

(asked on 24th July 2019) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 July to Question 272107 on Department of Health and Social Care: Brexit, whether his Department has assessed the average additional costs facing companies transferring medicines and medical equipment in the event that the UK leaves the EU without a deal.


Answered by
Chris Skidmore Portrait
Chris Skidmore
This question was answered on 9th September 2019

As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. It is a priority for the Department and industry to work together to put in place robust preparations to help ensure a continuous supply of medicines and medical products. We recognise suppliers may incur additional costs for their contingency planning, including storage costs, rerouting products and preparing for new border arrangements. We have been working closely with industry to minimise costs and are considering how best we might support suppliers in their contingency planning.

Reticulating Splines